A tribute: Abel Ayerza and pulmonary hypertension

Mazzei J.A., Mazzei M.E.

Source: Eur Respir Rev 2011; 20: 220-221
Journal Issue: December 2011 - 20 (122)

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Mazzei J.A., Mazzei M.E.. A tribute: Abel Ayerza and pulmonary hypertension. Eur Respir Rev 2011; 20: 220-221

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Chronic thromboembolic pulmonary hypertension: a tribute to pulmonary endarterectomy
Source: Eur Respir J 2009; 33: 230-232
Year: 2009


Pulmonary hypertension: where are we in 2007?
Source: ERS Live 2007
Year: 2007


Abernethy syndrome: A rare cause of pulmonary hypertension
Source: International Congress 2018 – Paediatric bronchology
Year: 2018


Mitomycin-induced pulmonary veno-occlusive disease: Experience from the French pulmonary hypertension network
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015


Asymptomatic bilateral pulmonary embolism in Churg–Strauss syndrome
Source: Eur Respir Rev 2012; 21: 75-77
Year: 2012


Limited and heterogeneous arterial narrowing in idiopathic pulmonary hypertension: Rethinking resistance
Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load
Year: 2015

Pulmonary arterial hypertension: an autoimmune disease?
Source: Eur Respir J 2005; 26: 986-988
Year: 2005


Pulmonary arterial hypertension masquerading as severe refractory asthma
Source: Eur Respir J 2008; 32: 513-516
Year: 2008



Reply to: Malnutrition in idiopathic pulmonary fibrosis: the great forgotten comorbidity!
Source: Eur Respir J, 53 (5) 1900615; 10.1183/13993003.00615-2019
Year: 2019



Pulmonary hypertension and pulmonary vascular disease: course report
Source: Breathe, 14 (1) e4; 10.1183/20734735.019917
Year: 2018



Pulmonary hypertension and chronic lung disease: where are we headed?
Source: Eur Respir Rev, 28 (153) 190065; 10.1183/16000617.0065-2019
Year: 2019



Reversibility of pulmonary arterial hypertension in HIV/HHV8-associated Castleman's disease
Source: Eur Respir J 2005; 26: 969-972
Year: 2005



Pulmonary veno-occlusive disease misdiagnosed as idiopathic pulmonary arterial hypertension
Source: Eur Respir Rev 2009; 18: 177-180
Year: 2009



A USA-based registry for pulmonary arterial hypertension: 1982 2006
Source: Eur Respir J 2007; 30: 1103-1110
Year: 2007



“Balloon pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension: is Europe behind?” Irene M. Lang and Hiromi Matsubara. Eur Respir J 2019; 53: 1900843.
Source: Eur Respir J, 54 (4) 1950843; 10.1183/13993003.50843-2019
Year: 2019


Chronic thromboembolic pulmonary hypertension associated with Klippel Trenaunay syndrome: A retrospective series of 5 patients
Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism
Year: 2011


Pulmonary hypertension: pathophysiology and diagnosis
Source: Annual Congress 2007 - PG19 - Pulmonary vascular disorders: diagnosis and treatment
Year: 2007